炎症性肠病
生物
组学
疾病
仿形(计算机编程)
生物信息学
计算生物学
内科学
医学
计算机科学
操作系统
作者
Jill O’Sullivan,Shriram H. Patel,Gabriel E. Leventhal,Rachel S. Fitzgerald,Emilio José Laserna Mendieta,Chloe E. Huseyin,Nina Konstantinidou,Erica M. Rutherford,Aonghus Lavelle,Karim Dabbagh,Todd Z. DeSantis,Fergus Shanahan,Andriy Temko,Shoko Iwai,Marcus Joakim Claesson
出处
期刊:Gut microbes
[Landes Bioscience]
日期:2025-01-15
卷期号:17 (1): 2450207-2450207
被引量:21
标识
DOI:10.1080/19490976.2025.2450207
摘要
Crohn's disease (CD) and ulcerative colitis (UC) are chronic relapsing inflammatory bowel disorders (IBD), the pathogenesis of which is uncertain but includes genetic susceptibility factors, immune-mediated tissue injury and environmental influences, most of which appear to act via the gut microbiome. We hypothesized that host-microbe alterations could be used to prognostically stratify patients experiencing relapses up to four years after endoscopy. We therefore examined multiple omics data, including published and new datasets, generated from paired inflamed and non-inflamed mucosal biopsies from 142 patients with IBD (54 CD; 88 UC) and from 34 control (non-diseased) biopsies. The relapse-predictive potential of 16S rRNA gene and transcript amplicons (standing and active microbiota) were investigated along with host transcriptomics, epigenomics and genetics. While standard single-omics analysis could not distinguish between patients who relapsed and those that remained in remission within four years of colonoscopy, we did find an association between the number of flares and a patient's succinotype. Our multi-omics machine learning approach was also able to predict relapse when combining features from the microbiome and human host. Therefore multi-omics, rather than single omics, better predicts relapse within 4 years of colonoscopy, while a patient's succinotype is associated with a higher frequency of relapses.
科研通智能强力驱动
Strongly Powered by AbleSci AI